Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
8m agoBachem Secures Financing of Strategic Growth Initiatives
1h agoe.l.f. Cosmetics Fuels Katherine Legge's Return to the Indianapolis 500 with eyes.lips.fuel. Takeover
1h agoInvestor Update Webcast March 2026 Quarter
2h agoCiti Singapore receives dual award recognition from FinanceAsia and Forbes
4h agoEyebright Medical Releases Its 2025 Annual Report and Sustainability Report
Seres Therapeutics Inc logo

Seres Therapeutics Inc

About

Seres Therapeutics Inc (NASDAQ:MCRB) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
Apr 9 2026
Seres Therapeutics to Present at CARB-X Investor Day
Mar 12 2026
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 2 2026
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Feb 12 2026
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

Financials

Revenue
$789 K
Market Cap
$88.86 M
P/E Ratio
14.48
EPS
0.64

Community Chat

Ask AI

6ix6ix